Skip to main content
Clinical Trials/NL-OMON35108
NL-OMON35108CompletedNot Applicable

A pilot study of scalp skin temperature during scalp cooling in patients treated with chemotherapy - FECtemp

Medisch Centrum Alkmaar0 sites12 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
12

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Intravenous administered FEC-regimen with an epirubicine dose of 90 mg/m2 or more at 3-weekly intervals, age 18 years or more, written informed consent

Exclusion Criteria

  • Boldness before the start of the study, hematological malignancies with generalized haematogenic metastases and clinical signs of scalp metastases

Investigators

Sponsor
Medisch Centrum Alkmaar

Similar Trials